查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466136

Cystatin C測量市場：按產品類型、檢測法、樣品類型、設定、應用和最終用戶 - 2024-2030 年全球預測

Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

Cystatin C測量市場規模預計 2023 年為 4.2747 億美元，2024 年將達到 4.5983 億美元，預計 2030 年將達到 6.9741 億美元，複合年成長率為 7.24%。

Cystatin C測量是一項用於測量Cystatin C水平的實驗室測試，胱抑素 C 是一種幾乎在體內每個細胞中產生的蛋白質。它在肌酸酐測量值誤導的特殊情況下最有用。腎臟疾病盛行率的增加和人口老化增加了對Cystatin C測量的需求。此外，先進的自動化測試方法的引入增加了Cystatin C的可用性和臨床採用，從而導致市場成長。相較之下，Cystatin C測量的製造成本較高且解釋指南嚴格，這限制了其採用。然而，一些供應商正在投資研發來克服這個問題。此外，診斷技術的進步、新研究以及有關Cystatin C測量的臨床指南的持續發布提供了巨大的市場成長機會。

主要市場統計
基準年[2023] 4.2747億美元
預測年份 [2024] 4.5983億美元
預測年份 [2030] 6.9741億美元
複合年成長率（%） 7.24%

消費者偏好Cystatin C分析儀用於產品診斷和疾病監測

Cystatin C分析儀是醫療設備。該設備對於診斷和監測腎臟疾病等疾病至關重要。Cystatin C套件旨在準確測量細胞培養上清液、血清、血漿、唾液、尿液和人類乳中的人類胱抑素 C。Cystatin C試劑被公認為可提供準確、精確結果的最高品質試劑。這是實驗室用來測量樣本中Cystatin C濃度的化學物質。多種方法和格式為任何規模的實驗室提供了彈性和選擇。

方法 擴大使用酵素結合免疫吸附檢測法(ELISA)Cystatin C測量

酵素結合免疫吸附檢測法(ELISA) 是一種使用抗體檢測和定量樣本中胱抑素 c 濃度的方法。 ELISA 方法以其敏感性和特異性而聞名，是臨床實驗室廣泛使用的一種方法，用於評估Cystatin C水平作為腎功能的標記。Cystatin C的化學冷光免疫檢測具有高靈敏度、寬動態範圍，通常是自動化的，可實現高效的高通量測試。由於其定量Cystatin C水平的精確性和準確性，它通常用於臨床實驗室。螢光使用螢光染料或蛋白質來標記Cystatin C抗體，並用顯微鏡或特殊設備檢測螢光。它在需要目視確認Cystatin C存在的研究環境和某些臨床情況下非常有用。顆粒增強比濁免疫檢測(PENIA)具有較高的靈敏度和準確性，適用於低濃度樣品，由於其在定量Cystatin C方面的準確性和可靠性而廣泛應用於臨床實驗室，特別是在腎功能評估中。顆粒增強比濁免疫檢測（PETIA）可測量Cystatin C存在下抗原抗體複合物形成引起的濁度，操作簡單且Cystatin C效益高，適合臨床實驗室常規使用。濃度，尤其是在大規模測試中。

擴大Cystatin C照護現場測量的使用

在實驗室環境中，Cystatin C測量是在配備專業設備和訓練有素的工作人員的臨床實驗室中進行的。從患者身上採集血液樣本，並使用先進的測試設備進行處理，以測量Cystatin C的濃度。這些環境允許進行深入分析和精確測量，通常提供更廣泛的測試和更高的吞吐量，但與照護現場環境相比，結果時間更慢，可能需要一些時間。在照護現場環境中，Cystatin C測量在患者現場或患者附近進行，例如在醫生辦公室、醫生辦公室或醫院的床邊。Cystatin C就地檢驗旨在提供快速結果，以便醫療保健提供者能夠立即做出臨床決策。這些測試通常更簡單、更快，並且需要最少的設備或專門培訓。這些測試對於快速評估以及在快速結果對於立即治療決策至關重要的情況下非常有用。

樣本類型尿液樣本，在Cystatin C測量中起著重要作用，可測量樣本中肌酸酐的含量

Cystatin C測量採用血液樣本，特別是血清和血漿。這些檢體對於評估作為腎功能生物標記的Cystatin C水平至關重要。血液檢體為臨床醫生提供診斷和監測病情（包括慢性腎臟病）的寶貴資訊，並提供對腎臟健康和過程的深入了解。用於測量Cystatin C 的尿液檢體用於測量尿液中Cystatin C的濃度。尿液中的Cystatin C顯示腎小管功能障礙和其他腎臟問題。選擇血液或尿液作為檢測法Cystatin C的方法通常取決於患者個體的需求和情況。這些方法提供了有價值的診斷見解，血液檢測提供了更傳統的方法，尿液檢測在無法進行血液採樣時提供了可行的替代方法。

擴大Cystatin C測量在腎功能診斷的應用

出於診斷目的，Cystatin C測量對於評估腎功能至關重要，可以及早發現和監測腎臟疾病。在臨床實踐中，它用於鑑別診斷、風險分層和個人化醫療保健。在研究和開發中，Cystatin C測量對於尋找生物標記以了解腎功能和疾病至關重要。它應用於臨床試驗和研究，以評估干預措施對腎臟健康的影響，並支持探索有助於腎臟研究進展的疾病機制。

擴大Cystatin C測量在最終用戶學術研究中心生物標記研究的應用

學術研究中心經常使用Cystatin C測量來研究腎功能和疾病。這包括研究早期檢測的生物標記、了解腎臟疾病的進展以及評估潛在治療方法的有效性。學術研究人員可以在生物標記發現計劃中使用Cystatin C測量來識別腎功能和疾病的新指標。診斷實驗室通常採用Cystatin C測量作為綜合腎功能測試組的一部分。這有助於早期發現腎功能障礙，並為臨床醫生提供患者管理的寶貴資訊。對於慢性腎臟病，診斷實驗室利用Cystatin C測量來持續監測患者。定期檢查可以追蹤腎功能的變化，並及時調整治療方案。在醫院和診所，Cystatin C測量可幫助醫療保健專業人員做出有關腎功能的臨床決策。數值升高需要進一步調查和調整患者照護。學術研究中心使用Cystatin C測量來推進科學知識，診斷實驗室使用它進行常規腎功能檢測和鑑別診斷。醫院和診所使用Cystatin C測量來進行腎臟疾病患者的臨床決策和管理。

區域洞察

北美，尤其是美國，擁有主要的醫療保健和診斷公司、研究機構和成熟的醫療基礎設施，對Cystatin C測量市場做出了重大貢獻。此外，美國食品藥物管理局(FDA) 和加拿大衛生署等政府監管機構的嚴格監管標準在Cystatin C測量的產品核可中發揮重要作用。在南美洲，人們對疾病早期診斷重要性的認知不斷提高以及醫療保健部門的不斷發展預計將導致對Cystatin C測量的需求不斷成長。在歐洲，德國、法國、瑞士和英國等國家由於其完善的醫療基礎設施、高支出以及對製藥和生物技術領域技術進步的關注，正在為更大程度地採用Cystatin C測量做出貢獻。在中東和非洲，由於人口成長導致慢性病盛行率不斷上升，以及醫療保健領域的大量投資提高了診斷能力，預計將推動該地區對Cystatin C測量的採用。在包括中國和日本在內的亞太地區國家，老年人口的增加和慢性病盛行率的上升正在促進市場的擴張。在中國、印度和澳洲等國家，人們對腎臟疾病的認知不斷提高，政府和當地醫療保健公司積極進行健康篩檢工作，推動了對Cystatin C測量等診斷測試的需求。在印尼、泰國和越南等新興國家，經濟發展、醫療保健普及以及對預防性醫療保健的重視正在推動Cystatin C測量的採用。

FPNV定位矩陣

FPNV 定位矩陣對於評估Cystatin C測量市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對Cystatin C測量市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.Cystatin C測量市場的市場規模和預測是多少？

2.在Cystatin C測量市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.Cystatin C測量市場的技術趨勢和法規結構是什麼？

4.Cystatin C檢測市場主要廠商的市場佔有率是多少？

5.進入Cystatin C檢測市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腎臟疾病盛行率上升和老年人口增加
      • 積極投資腎臟疾病醫療基礎設施
    • 抑制因素
      • Cystatin C檢測的開發成本高且產品召回率高
    • 機會
      • Cystatin C測量試驗的進展
      • 新研究採用Cystatin C測試取代基於肌酸酐的測試
    • 任務
      • 缺乏熟練的實驗室專業人員以及與Cystatin C測量相關的技術挑戰
  • 市場區隔分析
    • 產品：消費者首選的Cystatin C分析儀，用於診斷和狀態監測
    • 方法：擴大酵素結合免疫吸附檢測法(ELISA) 在Cystatin C測定中的應用
    • 背景：擴大Cystatin C檢測在照護現場環境中的使用
    • 樣本類型：尿液樣本對Cystatin C測量的重要作用，用於測量樣本中肌酸酐的量
    • 應用：擴大Cystatin C測定在腎功能診斷的應用
    • 最終用戶：擴大Cystatin C測定在學術研究中心的生物標記研究中的使用
  • 市場趨勢分析
    • 建立醫療保健基礎設施並專注於在美洲Cystatin C測量解決方案商業化
    • 政府支持的減輕亞太地區腎臟疾病負擔的計劃
    • 專注於在 EMEA 地區開發和擴展新的Cystatin C檢測產品
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第 6 章Cystatin C測量市場：依產品

  • 分析儀
  • 套件
  • 試劑

第 7 章Cystatin C測量市場：按方法

  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 螢光測定
  • 顆粒增強免疫檢測
  • 顆粒增強免疫檢測

第 8 章Cystatin C測量市場（依樣本類型）

  • 血
  • 尿

第 9 章Cystatin C測量市場的建立

  • 實驗室設置
  • 照護現場設置

第 10 章Cystatin C測量市場：依應用分類

  • 使用診斷
  • 研究與開發

第 11 章Cystatin C測量市場：依最終用戶分類

  • 學術研究中心
  • 診斷實驗室
  • 醫院/診所

第12章 美洲Cystatin C測量市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區Cystatin C測量市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲的Cystatin C測量市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Jana Care 融資 600 萬美元用於自我血液檢測商業化
    • RhodesMed 宣佈在馬哈拉斯特拉邦開設第一個病理中心
    • Renalyse 完成 100 萬歐元資金籌措，GENESIS Ventures 參與
    • Renalytix 選擇 EVERSANA 擴大 KidneyIntelX 的商業化，用於 2 型糖尿病患者腎臟疾病的早期預後檢測
    • 歐洲新的 eGFRCystatin C公式可能更準確
    • Jana Care 與羅氏合作開發和分銷血液檢測平台，以改善慢性腎臟病和心臟病患者的遠距護理
    • Gentian Diagnostics ASA 簽署Cystatin C經銷協議
    • Bloom Diagnostics 宣布新的腎臟測試

第16章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-2E76C3E47F4F

[194 Pages Report] The Cystatin C Assay Market size was estimated at USD 427.47 million in 2023 and expected to reach USD 459.83 million in 2024, at a CAGR 7.24% to reach USD 697.41 million by 2030.

The cystatin C assay is a laboratory test utilized to measure the levels of cystatin C, a protein produced by nearly all cells in the body. It is most useful in exceptional cases where creatinine measurement could be misleading. The increasing prevalence of kidney diseases and the growing geriatric population drive the need for cystatin C assay. Furthermore, the increasing availability and clinical adoption of cystatin C with the introduction of advanced automated testing methods have led to its market growth. In contrast, the high manufacturing costs of cystatin C assays and strict interpretation guidelines restrict their adoption. However, several vendors are investing in R&D to overcome its issues. Furthermore, advancements in diagnostics technologies, emerging research, and ongoing publishing of clinical guidelines for cystatin C assay provide substantial market growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 427.47 million
Estimated Year [2024] USD 459.83 million
Forecast Year [2030] USD 697.41 million
CAGR (%) 7.24%

Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions

A cystatin C analyzer is a medical device used to measure cystatin c concentration. This device is crucial for diagnosing and monitoring conditions such as kidney disease. Cystatin C kits are designed to accurately measure human cystatin c in cell culture supernatants, serum, plasma, saliva, urine, and human milk. Cystatin C reagents are recognized as being of the highest quality, producing accurate and precise results. It is a chemical substance used in the laboratory to measure cystatin C levels in the sample. A wide range of methods and formats provide greater flexibility and choice for any laboratory size.

Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays

The enzyme-linked immunosorbent assay (ELISA) method involves using antibodies using antibodies to detect and quantify the cystatin c levels in a sample. ELISA is known for its sensitivity and specificity, making it a widely used method in clinical laboratories for assessing cystatin C levels as a marker for renal function. A chemiluminescent immunoassay for cystatin C offers high sensitivity and wide dynamic range and is often automated, enabling efficient high-throughput testing. It is commonly used in clinical laboratories for its precision and accuracy in quantifying cystatin C levels. Immunofluorescence assay utilizes fluorescent dyes or proteins to label cystatin C antibodies, and fluorescence is detected under a microscope or specialized instrument. It is useful in research settings and specific clinical scenarios requiring visual confirmation of cystatin C presence. Particle-enhanced nephelometric immunoassay (PENIA) offers high sensitivity and precision, is suitable for low-concentration samples, and is widely used in clinical laboratories for its accuracy and reliability in quantifying cystatin C, especially in renal function assessment. Particle-enhanced turbidimetric immunoassay (PETIA) measures the degree of turbidity caused by the formation of antigen-antibody complexes in the presence of cystatin C. It is simple, cost-effective, suitable for routine clinical use, and commonly employed in clinical laboratories to quantify cystatin C levels, especially in large-scale testing.

Setting: Expanding usage of point-of-care setting for cystatin C assays

In a laboratory setting, cystatin C assay is performed in clinical laboratories equipped with specialized equipment and trained personnel. Blood samples are collected from patients and then processed using advanced laboratory instruments to measure the levels of cystatin C. This setting allows for meticulous analysis and precise measurements, often offering a wider range of tests and higher throughput, although it might take longer to generate results compared to point-of-care settings. In a point-of-care setting, the cystatin C assay is conducted at or near the patient's location, such as within a clinic, doctor's office, or at the bedside in a hospital. Point-of-care tests for cystatin C are designed to provide rapid results, allowing healthcare providers to make immediate clinical decisions. These tests are often simpler, quicker, and require minimal equipment or specialized training. They are beneficial for quick assessments or situations where rapid results are crucial for immediate treatment decisions.

Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample

The cystatin C assay employs blood samples, specifically serum and plasma. These samples are vital for evaluating cystatin C levels as a biomarker for kidney function. Blood samples provide clinicians with valuable information to diagnose and monitor conditions, including chronic kidney disease, offering insights into renal health and processes. Urine samples for cystatin c assay involve measuring the concentration of cystatin c in the urine. Cystatin C in urine indicates tubular dysfunction and other renal issues.The choice between blood and urine assays for cystatin C often relies on individual patient needs and circumstances. These methods provide valuable diagnostic insight, with blood assays offering a more traditional approach and urine assays providing a viable alternative when blood sampling is untenable.

Application: Increasing application of cystatin C assays for diagnosis of renal function

For diagnostic use, cystatin C assays are vital for assessing renal function, enabling early detection and monitoring of kidney diseases. It is used in differential diagnosis, risk stratification, and personalized healthcare in clinical settings. For research & development, cystatin C assays are integral in biomarker discovery for understanding kidney function and diseases. It is applied in clinical trials and studies to evaluate the impact of interventions on kidney health, and supports the exploration of disease mechanisms, contributing to advancements in renal research.

End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers

Academic research centers often utilize cystatin C assays to investigate kidney function and diseases. This includes studying biomarkers for early detection, understanding the progression of renal disorders, and assessing the effectiveness of potential treatments. Academic researchers can use cystatin C assays in biomarker discovery projects to identify novel indicators of kidney function or diseases. Diagnostic laboratories routinely employ cystatin C assays as part of comprehensive renal function testing panels. This helps in the early detection of kidney dysfunction and provides clinicians with valuable information for patient management. In cases of chronic kidney diseases, diagnostic laboratories utilize cystatin C assays for ongoing monitoring of patients. Regular testing helps track changes in kidney function and allows for timely adjustments to treatment plans. In hospitals and clinics, cystatin C assays aid healthcare professionals in making clinical decisions related to kidney function. Elevated levels may prompt further investigation or adjustments in patient care. The objective of academic research centers to use cystatin C assays is to focus on advancing scientific knowledge, while diagnostic laboratories use it for routine kidney function testing and differential diagnosis. Hospitals & clinics use cystatin C assays for clinical decision-making and management of patients with kidney disorders.

Regional Insights

In North America, particularly in the U.S., the presence of major healthcare and diagnostic companies, research institutions, and well-established healthcare infrastructure is a significant contributor to the cystatin C assay market. Moreover, stringent regulatory standards laid by government regulatory agencies, including the U.S. Food and Drug Administration (FDA) and Health Canada, play a crucial role in product approvals for cystatin c assay. In South America, increasing awareness about the importance of early disease diagnosis and a growing healthcare sector is expected to contribute to the expanding need for cystatin C assay. In Europe, countries such as Germany, France, Switzerland, and the United Kingdom are contributing to the growing adoption of cystatin C assay as they have well-established healthcare infrastructure with high spending and a focus on technological advancements in the pharmaceutical and biotechnology sectors. In the Middle East and Africa, the growing prevalence of chronic diseases with increasing population and a focus on improving diagnostic capabilities with investing heavily in the healthcare sector is expected to bolster the usage of cystatin C assay in the region. In APAC countries, including China and Japan, the increasing number of geriatric residents and the rising prevalence of chronic diseases contribute to the expansion of the market. In countries including China, India, and Australia, increasing awareness of kidney diseases and proactive health screening initiatives by government and regional healthcare companies increase the need for diagnostic tests such as cystatin c assay. In emerging nations such as Indonesia, Thailand, and Vietnam, economic development, expanding healthcare access, and an emphasis on preventive healthcare support the application of cystatin C assay in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cystatin C Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cystatin C Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Analyzer
    • Kits
    • Reagents
  • Method
    • Chemiluminescence Immunoassay
    • Enzyme linked Immunosorbent Assay
    • Immunofluorescence Assay
    • Particle-enhanced Nephelometric Immunoassay
    • Particle-enhanced Turbidimetric Immunoassay
  • Sample Type
    • Blood
    • Urine
  • Setting
    • Laboratory Setting
    • Point of Care Setting
  • Application
    • Diagnosis Use
    • Research & Development
  • End-user
    • Academic Research Centers
    • Diagnostic Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cystatin C Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cystatin C Assay Market?

3. What are the technology trends and regulatory frameworks in the Cystatin C Assay Market?

4. What is the market share of the leading vendors in the Cystatin C Assay Market?

5. Which modes and strategic moves are suitable for entering the Cystatin C Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
      • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in cystatin C assay testing
      • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
    • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
    • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
    • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
    • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
    • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established healthcare infrastructure coupled with emphasis on commercializing Cystatin C Assay solutions in the Americas
    • 5.3.2. Supportive government programs to reduce the burden of renal disorders in the Asia-Pacific region
    • 5.3.3. Growing focus on developing and expanding novel cystatin C assays products in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Cystatin C Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Kits
  • 6.4. Reagents

7. Cystatin C Assay Market, by Method

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme linked Immunosorbent Assay
  • 7.4. Immunofluorescence Assay
  • 7.5. Particle-enhanced Nephelometric Immunoassay
  • 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Urine

9. Cystatin C Assay Market, by Setting

  • 9.1. Introduction
  • 9.2. Laboratory Setting
  • 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnosis Use
  • 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

  • 11.1. Introduction
  • 11.2. Academic Research Centers
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
    • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
    • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
    • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
    • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
    • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
    • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
    • 15.3.8. Bloom Diagnostics Launches New Kidney Test

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. CYSTATIN C ASSAY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 27. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2023 (USD THOUSAND)
  • TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2024-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 30. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 32. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 33. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 34. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 35. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 36. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 37. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 38. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 39. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 40. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 41. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 42. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 43. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 44. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 45. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 46. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 47. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 48. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 49. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 50. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 51. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 52. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 53. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 54. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 55. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 56. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 57. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 58. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 59. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 60. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 61. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 62. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 63. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 64. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 65. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 66. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 67. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 68. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 69. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 70. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 71. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 72. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 73. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 74. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 75. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 76. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 77. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 78. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 79. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 80. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 81. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 82. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 83. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 84. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 85. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 86. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 87. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 88. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 89. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 90. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 91. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 92. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 93. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 94. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 95. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 96. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 97. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 98. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 99. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 100. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 101. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 102. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 103. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 104. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 105. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 106. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 107. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 108. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 109. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 110. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 111. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 112. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 113. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 114. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 115. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 116. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 117. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 118. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 119. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 120. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 121. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 122. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 123. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 124. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 125. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 126. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 127. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
  • TABLE 128. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
  • TABLE 129. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 130. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 131. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 132. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 133. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 134. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 135. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 136. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 137. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 138. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 139. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 140. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 141. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 142. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 143. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 144. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 145. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 146. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 147. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 148. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 149. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 150. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 151. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 152. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 153. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 154. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 155. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 156. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 157. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 158. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 159. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 160. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 161. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 162. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 163. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 164. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 165. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 166. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 167. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 168. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 169. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 170. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 171. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 172. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 173. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 174. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 175. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 176. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 177. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 178. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 179. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 180. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 181. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 182. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 183. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 184. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 185. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 186. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 187. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 188. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 189. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 190. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 191. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 192. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 193. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 194. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 195. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 196. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 197. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 198. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 199. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 200. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 201. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 202. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 203. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 204. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 205. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 206. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 207. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 208. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 209. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 210. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 211. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 212. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 213. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 214. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 215. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 216. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 217. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 218. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 219. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 220. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 221. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 222. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 223. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 224. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 225. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 226. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 227. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 228. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 229. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 230. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 231. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 232. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 233. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 234. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 235. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 236. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 237. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 238. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 239. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 240. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 241. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 242. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 243. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 244. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 245. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 246. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 247. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 248. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 249. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 250. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 251. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 252. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 253. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 254. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 255. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 256. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 257. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 258. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 259. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 260. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 261. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 262. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 263. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 264. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 265. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 266. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 267. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 268. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 269. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 270. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 271. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 272. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 273. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 274. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 275. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 276. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 277. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 278. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 279. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 280. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 281. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 282. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 283. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 284. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 285. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 286. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 301. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 302. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 303. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 304. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 305. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 306. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 307. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 308. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 309. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 310. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 311. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 312. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 313. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 314. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 315. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 316. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 317. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 318. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 319. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 320. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 321. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 322. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 323. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 324. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 325. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 326. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 327. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 328. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 329. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 330. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 331. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 332. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 333. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 334. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 335. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 336. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 337. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 338. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 339. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 340. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 341. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 342. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 343. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 344. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 345. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 346. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 347. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 348. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 349. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 350. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 351. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 352. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 353. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 354. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 355. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 356. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 357. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 358. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 359. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 360. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 361. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 362. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 363. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 364. ISRAEL CYSTATIN C ASSAY